This excerpt taken from the ELN 20-F filed Feb 26, 2009.
We Offer to Clients:
A broad range of creative drug optimization
approaches including formulation development, scale-up and
Athlone, Ireland, FacilityLocated on a 40-acre site with over 200,000 sq ft of dedicated GMP grade facilities, Elan Drug Technologies has a proven manufacturing track-record 30 products optimized and manufactured for over 90 countries worldwide. The facility has a capacity of 3 billion unit doses per annum.
Our NanoCrystal technology offers superior
results for poorly water-soluble compounds that can be
incorporated into common dosage forms. This technology has been
applied in four products contributing to over $1.5 billion
annual in-market sales for our clients.
Range of customized oral drug technologies such as
extended release, delayed release and pulsatile release have all
been developed and commercialized.
Suite of more than 1,700 patents/pending patents
protecting our technology-based solutions.
FDA/European Medicines Agency approved manufacturing
and packaging capabilities in the United States and Europe for
solid oral dosage forms with annual capacity of 3 billion units.
Other services include analytical development,
clinical trial manufacturing, product registration support and
supply chain management for client products.
Bet you've never seen portfolio analytics like these.